"NorthShore University HealthSystem (NorthShore) is an integrated healthcare delivery system consistently ranked as a Top 15 Teaching Hospital in the U.S. The NorthShore system, headquartered in Evanston, Ill., includes four hospitals – Evanston, Glenbrook, Highland Park and Skokie. NorthShore also includes a 900 physician multispecialty group practice, NorthShore Medical Group, with 130 locations in the Chicagoland area. NorthShore has annual revenues of $2.1 billion and employs 10,500 people."

During the past decade, NorthShore University HealthSystem-Highland Park Hospital conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 41 clinical trials were completed, i.e. on average, 40.6% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 36 clinical trials were completed. i.e. 83.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NorthShore University HealthSystem-Highland Park Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 57 trials, followed by "Alliance for Clinical Trials in Oncology" with 19 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NorthShore University HealthSystem-Highland Park Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 61 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator and "Advocate Health Care" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "NorthShore University HealthSystem-Highland Park Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Lung Non-Small Cell Carcinoma" (7 trials), "Recurrent Ovarian Carcinoma" (5 trials) and "Stage II Breast Cancer" (5 trials). Many other conditions were trialed in "NorthShore University HealthSystem-Highland Park Hospital" in a lesser frequency.

Most popular intervention types in "NorthShore University HealthSystem-Highland Park Hospital" are "Drug" (99 trials), "Other" (82 trials), "Biological" (55 trials), "Procedure" (45 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (40 trials), "Laboratory Biomarker Analysis" (33 trials), "Questionnaire Administration" (26 trials), "Biospecimen Collection" (24 trials) and "Computed Tomography" (24 trials). Other intervention names were less common.

The vast majority of trials in "NorthShore University HealthSystem-Highland Park Hospital" are 98 trials for "All" genders, 21 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "NorthShore University HealthSystem-Highland Park Hospital". undefined are not yet recruiting, 36 are recruiting, 63 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in NorthShore University HealthSystem-Highland Park Hospital, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in NorthShore University HealthSystem-Highland Park Hospital, 4 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".